Volcon Inc (NASDAQ:VLCN) has received thousands of non-binding pre-production orders, which, if finalized, would result in more than $70 million worth…
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.